Epalrestat (EPS), an aldose reductase inhibitor, is widely prescribed to manage diabetic neuropathy. It is generally believed that EPS is beneficial to diabetic patients because it can protect endothelial cells, Schwann cells, or other neural cells from oxidative stress. However, several clinical studies revealed that EPS therapy led to liver dysfunction, which limited its clinical applications. Currently, the underlying mechanism by which EPS causes liver dysfunction is unknown. This study aimed to investigate the mechanism responsible for EPS-induced liver injury. In mouse liver, EPS 1) increased oxidative stress, indicated by increased expression of manganese superoxide dismutase, Ho-1, and Nqo1, 2) induced inflammation, indicated by infiltration of inflammatory cells, and induced expression of tumor necrosis factor-alpha, CD11b, and CD11c, as well as 3) predisposed to induce fibrosis, evidenced by increased mRNA and protein expression of early profibrotic biomarker genes procollagen I and alpha-smooth muscle actin, and by increased collagen deposition. In cultured mouse and human hepatoma cells, EPS treatment induced oxidative stress, decreased cell viability, and triggered apoptosis evidenced by increased Caspase-3 cleavage/activation. In addition, EPS increased mRNA and protein expression of cytoglobin in mouse liver, indicating that EPS activated hepatic stellate cells (HSCs). Furthermore, EPS treatment in cultured human HSCs increased cell viability. In summary, EPS administration induced oxidative stress and inflammation in mouse liver, and stimulated liver fibrogenesis. Therefore, cautions should be exercised during EPS therapy.
Epalrestat (EPS), an aldose reductase inhibitor, is widely prescribed to treat diabetic neuropathy (Goto et al., 1993 (Goto et al., , 1995 Hotta et al., 1990; Kuriya et al., 1987; Ramirez and Borja, 2008; Steele et al., 1993; Uchida et al., 1995) . Aldose reductase is the rate-limiting enzyme in the polyol pathway, which is activated under hyperglycemic conditions (Gabbay, 1975) . Activation of polyol pathway leads to sorbitol production and intracellular accumulation as well as production of oxidative stress, which in turn contribute to the pathogenesis of diabetic neuropathy complications (Hotta, 1997; Oates, 2002; Steele et al., 1993) . Diabetic neuropathy is the most common long-term and perhaps the most devastating complication for diabetic patients (Brooks and Francisco, 1992) . By inhibiting aldose reductase, EPS repressed the polyol pathway and thus relieved diabetic neuropathy symptoms, such as improving motor nerve conduction velocity, sensory nerve conduction velocity (SNCV), F-wave latency, and vibration perception threshold (VPT) (Goto et al., 1995; Hotta et al., 1996a Hotta et al., ,b, 2012 Matsuoka et al., 2007; Ramirez and Borja, 2008; Steele et al., 1993) . However, during EPS clinical studies and post-marketing surveillances, several adverse effects have been noticed (Fujise et al., 2011; Hotta et al., 1996b Hotta et al., , 2008 Sharma and Sharma, 2008) . The most common observed adverse effect of EPS is hepatic dysfunction, accounting for one-third of reported adverse effects.
Previous studies showed that EPS protected endothelial cells and Schwann cells by inhibiting polyol pathway and thus repressing oxidative stress (Sato et al., 2013; Yama et al., 2015 Yama et al., , 2016 . However, during these studies, it was also observed that EPS decreased cell viability and up-regulated Caspase-3 activity in endothelial cells and Schwann cells. Currently, the impact of EPS on the viability of hepatic cells has not been reported. In addition, the types and pathology of liver disorders caused by EPS remain uncharacterized.
We reported here that EPS paradoxically induced oxidative stress in mouse and human hepatoma cells as well as in mouse liver. Furthermore, although it did not cause acute liver injury, EPS caused liver inflammation and predisposed to induce liver fibrosis via activation of hepatic stellate cells (HSCs).
MATERIALS AND METHODS

EPS (5-[(1Z,2E
)-2-methyl-3-phenylpropenylidene]-4-oxo-2-thioxo-3-thiazolidineaceticacid) was purchased from Ark pharm (Libertyville, Illinois). MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] was purchased from Alfa Aesar (Haverhill, Massachusetts). Trypan blue reagent was purchased from Corning (Corning, New York). BLOXALL reagent, alkaline phosphatase (AP) conjugated streptavidin and 5-bromo-4-chloro-3-indolyl-phosphate/nitro-bluetetrazolium (BCIP/NBT) AP substrate Kit were all purchased from Vector Laboratories (Burlingame, California). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) reagents were purchased from Pointe Scientific (Ann Arbor, Michigan). All other reagents and chemicals, unless specifically indicated, were purchased from Thermo Fisher Scientific (Waltham, Massachusetts) .
Mouse/human Nrf2 (Cat. no. ab31163), mouse Collagen-I (Cat. no. ab34710), and active Caspase-3 (Cat. no. ab2302) antibodies were all purchased from Abcam (Cambridge, Massachusetts). b-actin antibody (Cat no. AM1021B) was purchased from Abgent (San Diego, California Nakagaki et al., 2013) . In our studies, the mice were orally administered with 30, 100, and 300 mg/kg EPS (dissolved in corn oil) once daily for 14 days (n ¼ 6/treatment). The control group received corn oil by gavage. All drugs were administered in a volume of 5 ml/kg. Fifteen days later, blood was collected from submandibular vein from anesthetized mice by using Goldenrod Animal Lancet (Braintree Scientific, Inc., Braintree, Massachusetts). Then, mouse serum was isolated and refrigerated for further analysis. Livers were collected. One piece of liver was frozen in precooled heptane for histology study. Another piece of liver was embedded in 10% formalin and then processed for Trichrome staining by Mass Histology Service (Worcester, Massachusetts). The liver remnants were chopped, snap-frozen in liquid nitrogen and stored at À80 C for further use.
Hematoxylin and Eosin Staining. The frozen mouse liver samples were snap frozen in precooled heptane. Five-lm thickness sections were prepared using cryo-sectioning instruments. The sections were fixed with 4% paraformaldehyde and stained with hematoxylin for 13 min, next rinsed with water for 5 min and then PBS for 10 min twice. The sections were then stained with Eosin Y for 30 s followed by 50% ethanol rinse for 30 s, 70% ethanol for 30 s, 95% ethanol for 30 s, 100% ethanol for 1 min, and twice rinses in 100% xylene for 1 min. Sections were mounted with Permount Mounting Medium and the images were taken by Micromaster Inverted Digital Microscope (Thermo Fisher Scientific, Fairlawn, New Jersey). Vacuolization area scoring and inflammation foci scoring of EPS-treated mouse liver sections were evaluated by using ImageJ software (downloaded from NIH website at https://imagej.nih.gov/ij/download.html), based on previously described methods (Lee, 2016; Ye et al., 2016) .
RNA Extraction, cDNA Synthesis, and Quantitative Real-Time PCR.
Total RNA was extracted from cultured hepatoma cells or mouse liver using TRIzol reagent (Life Technologies, Grand Island, New York) according to the manufacturer's instructions. Harvested RNA was dissolved in diethyl pyrocarbonate-treated deionized water. Formaldehyde agarose gel electrophoresis was performed to test RNA integrity. RNA concentrations were quantified spectrophotometrically at 260 nm using Eppendorf Biospectrometer (Hauppauge, New York). Four lg of extracted RNA was used to synthesize complementary cDNA using SuperScript II Reverse Transcriptase kit (Thermo Fisher Scientific, Fairlawn, New Jersey) according to the manufacturer's instructions. Messenger RNA expression of individual gene was quantified by AriaMx qPCR instrument (Agilent Technologies, Santa Clara, California). Messenger RNA levels of genes were normalized to 18S rRNA expression and expressed as relative fold changes. Real-time PCR primers were shown in Table 1 .
Protein Extraction. Protein was extracted from cultured hepatoma cells and mouse liver. For protein extraction from hepatoma cells: hepatoma cells were cultured in T-75 flasks and treated with 50 and 100 lM EPS for 48 h. After treatment, nuclear protein was extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagent kit (Pierce Biotechnology, Inc., Rockford, Illinois) according to the manufacturer's instructions. For protein extraction from mouse liver: freshly collected mouse liver was homogenized using Dounce homogenizer. The protein concentrations were quantified spectrophotometrically at 280 nm.
Western Blotting. The protein samples (60 lg protein/lane) were resolved on a 12% SDS-PAGE gel. After gel running, protein was transferred to a polyvinylidene difluoride membrane and blocked in Tris-buffered saline (TBS) buffer supplemented with 5% nonfat milk for 2 h at room temperature. Membranes were then incubated with Nrf2 antibody (1:1000 in 2.5% nonfat milk in TBS), Histone H3 antibody (1:1000 in 5% nonfat milk in TBS), or cytoglobin antibody (1:1000 in 2.5% nonfat milk in TBS) at 4 C overnight. After 3 times wash with TBS, membranes were incubated with secondary antibody (antirabbit secondary antibody for Nrf2 protein or cytoglobin protein; for Histone H3, goat antirabbit IgG biotin conjugate) for 2.5 h. For Histone H3 protein Western blot, the membrane was further incubated with high sensitivity streptavidin-HRP (1:5000 in TBS containing 0.5% BSA and 10 mM HEPES) at room temperature for 30 min. Target protein bands were detected with Immobilon Chemiluminescence reagent (Cat. no. WBKLS0100; Millipore, Billerica, Massachusetts) and protein bands were visualized by Biospectrum Imaging system (UVP, Upland, California). The intensity of protein bands was quantified with ImageJ software (NIH). 
Immunohistochemistry. Five-lm thickness liver sections were fixed with 4% paraformaldehyde to Fisherfinest Premium microscope slides (Thermo Fisher Scientific, Fairlawn, New Jersey). Endogenous AP was blocked by BLOXALL reagent by incubation for 10 min at room temperature. Slides were then permeabilized by PBS-0.2% Triton X-100 (twice 5-min incubation) and blocked with 5% normal goat serum/PBS incubation for 60 min at room temperature. Following brief washing with PBS, primary antibody was added (1:400 dilution for Collagen-1 antibody and 1:100 dilution for Cytoglobin antibody in PBS-0.5% goat serum) and incubates for 1 h in a humidified chamber at 37 C and then overnight at 4 C. Following primary antibody incubation, slides were incubated with biotinylated goat antirabbit IgG secondary antibody (1:500 dilution in PBS-0.5% goat serum) for 4 h at room temperature. Following secondary antibody incubation and PBS wash, the slides were incubated with AP-conjugated streptavidin (10 mM; 1:250 dilution in PBS-0.5% BSA-HEPES; pH7.4;) for 1 h at room temperature. Comparisons between control and EPS-treated group were analyzed by Student's t test. Comparisons between more than 2 treatment groups were analyzed by 1-way ANOVA followed by Duncan's post hoc tests (Sigmaplot, Systat Software, Inc., California). The statistical significance is considered at P < .05.
RESULTS
EPS Impaired Viability of Cultured Mouse and Human Hepatoma Cells
As shown in Figure 1A , MTT assays showed that EPS treatment concentration-dependently decreased cell density of both mouse Hepa1c1c7 and human Hep3B cells. Specifically, EPS at 3, Asterisks indicate statistical difference between EPS-treated group and control group (P < 05).
10, and 30 mM had no effect on cell density. However, EPS at 100 and 300 mM significantly reduced cell viability. Then, we performed Trypan blue exclusion assays by focusing on higher EPS concentrations. As shown in Figure 1B , 100 and 150 mM EPS decreased cell density and increased positively stained cell number. These results suggested that EPS, especially at high concentrations, interfered with cell growth and caused apparent cell death in cultured hepatoma cells.
EPS Produced Oxidative Stress and Activated Nrf2 in Cultured Hepatoma Cells
Flow cytometry assays showed that in cultured mouse Hepa1c1c7 cells, oxidative stress was detected in only 1.7% of total cell population ( Figure 2A, upper panel) . In contrast, 100 and 150 lM EPS increased the percentage of oxidative stresspositive cell population to 13.1 and 35.7%, respectively. Similarly, in human Hep3B cells, EPS also caused an increase in oxidative stress-positive cell population compared with control treatment (Figure 2A, lower panel) . Therefore, EPS induced oxidative stress in both mouse and human hepatoma cells.
Oxidative stress often leads to activation of Nrf2 and consequently induces the expression of its target genes such as Heme oxygenase (Ho)-1 and NADPH:quinone oxidoreducase (Nqo)-1. As shown in Figure 2B , EPS treatment concentrationdependently increased mRNA expression of Ho-1/HO-1 and Nqo-1/NQO-1 in cultured mouse and human hepatoma cells. Nrf2 activation is indicated by nuclear translocation of Nrf2 protein. As shown in Figures 2C and D , EPS concentrationdependently increased nuclear Nrf2 protein levels in mouse Hepa1c1c7 and human Hep3B cells. Therefore, EPS increased production of oxidative stress and activated Nrf2 in cultured hepatoma cells.
Effects of EPS on the Caspase-3 Cleavage
Oxidative stress often leads to cell death through apoptosis. We further determined whether apoptosis is involved in EPSdecreased cell viability. In the apoptotic cells, Caspase-3 is activated via cleavage by initiator Caspases. By using the antibody that specifically recognizes active form of Caspase-3, we performed immunocytostaining in EPS-treated hepatoma cells. As were determined by quantitative real-time PCR. Effects of EPS on nuclear Nrf2/NRF2 protein levels in cultured mouse (C) and human (D) hepatoma cells. Mouse Hepa1c1c7 and human Hep3B hepatoma cells, in triplicate, were treated with 50 and 100 lM EPS for 48 h. Control received 0.1% DMSO. Nuclear protein levels of Nrf2/ NRF2 were expressed as the ratio of Nrf2/NRF2 to Histone H3. All data are expressed as mean 6 SE. Asterisks indicate statistical difference between EPS treatment and control group (P < .05).
shown in Figure 3A , 100 and 150 mM EPS decreased cell number and markedly increased the percentage of cells, which are active Caspase-3 positive in mouse hepatoma cells. Similarly, in cultured human hepatoma cells, EPS concentrationdependently decreased cell number and increased the percentage of cells that are active Caspase-3 positive. Therefore, EPS enhanced apoptosis in cultured mouse and human hepatoma cells ( Figure 3B ).
Impact of EPS on Mouse Liver Histology
Hematoxylin and Eosin (H&E) staining showed that EPS, especially at the doses of 100 and 300 mg/kg, increased vacuolization in the cytoplasm and caused clear infiltration of inflammatory cells ( Figure 4A ). In contrast, control group or 30 mg/kg EPS did not cause apparent vacuolization or inflammation in mouse liver. ImageJ analysis of the images of EPS-treated liver sections demonstrated that EPS dose-dependently decreased cell density of liver sections. In addition, EPS administration dosedependently increased the number of inflammation foci.
Impact of EPS on Serum ALT and AST Levels
Serum levels of ALT and AST are biomarkers of liver injury. As shown in Figure 4B , EPS did not increase serum ALT levels. 30 and 100 mg/kg EPS did not increase serum levels of AST. Only 300 mg/kg EPS marginally increased serum AST levels. Therefore, EPS did not cause acute liver injury. Figure 4A showed that EPS caused infiltration of inflammatory cells. We next determined whether EPS up-regulated tumor necrosis factor-a (TNF-a), an inflammatory cytokine. As shown in Figure 5A , EPS dose-dependently increased mRNA expression of TNF-a. This further demonstrated that EPS induced inflammation in mouse liver.
EPS Increased Tumor Necrosis Factor-a and Fgf21 mRNA Expression in Mouse Liver
Fgf21 is a metabolic regulator of lipid and glucose metabolism. Recent studies showed that Fgf21 plays a cyto-protective role by fighting against chemical-induced toxicities, such as of dioxins, acetaminophen, and alcohols (Cheng et al., 2014; Ye et al., 2014; Zhu et al., 2014) . In addition, Fgf21 attenuated the progression of hepatic fibrogenesis (Xu et al., 2016) . Moreover, increasing evidences demonstrated that Fgf21 is a biomarker of mitochondrial injury. In this study, we showed that EPS, at all doses, increased Fgf21 mRNA expression in mouse liver. This indicated that EPS administration impaired mitochondria function in mouse liver.
EPS Increased Oxidative Stress in Mouse Liver
Generation of oxidative stress is often characterized by activation of Nrf2 and increased expression of mitochondrial manganese superoxide dismutase (MnSOD) (Itoh et al., 1999; Janssen et al., 1993) . As shown in Figure 5A , EPS dosedependently increased mRNA expression of Ho-1 and Nqo-1, 2 well-known target genes of Nrf2 signaling. We also showed that EPS dose-dependently increased MnSOD mRNA expression. Therefore, EPS increased mitochondria-derived oxidative stress.
EPS Tended to Induce Liver Fibrosis in Mice
Liver fibrosis is a chronic injury. As compared with cirrhosis, liver fibrosis is reversible. Therefore, early diagnosis is critical to treat liver fibrosis. Liver fibrosis is characterized by increased expression of profibrogenic genes. As shown in Figure 5B , EPS increased mRNA expression of procollagen-1 and alpha-smooth muscle actin (SMA), 2 early profibrotic biomarker genes, in a dose-dependent manner. In addition, we showed that EPS increased mRNA expression of cytoglobin, a biomarker indicating activation of HSCs. Immunohistochemistry further showed that EPS dose-dependently increased Collagen-I protein expression in mouse liver ( Figure 5C ). In control group, Collagen-I staining only appeared in the portal/periportal regions. In contrast, EPS, especially at the doses of 100 and 300 mg/kg, markedly increased extracellular Collagen-I protein staining, further indicating that EPS induced liver fibrosis. Trichrome staining showed that in control-treated mouse liver, blue staining, which is positive to Collagen-I protein, is restricted to around blood vessel ( Figure 5D ). However, EPS administration leads to dotted blue staining across the liver sections, especially at the liver Mice were orally administrated with 30, 100, and 300 mg/kg of EPS once daily for 14 days. Formalin-preserved mouse livers were processed for H&E staining. The arrows point to foci of inflammation in mouse liver (400Â amplification). Bottom panel, vacuolization area scoring of liver sections (Top panel) was determined by ImageJ, as described previously (Ye et al., 2016) (n¼ 5 images/treatment). In addition, inflammation foci were counted in 20 consecutive fields in each group (Bottom). Grade 0: no inflammation foci per field; Grade 1: <2 foci per field; Grade 2: !2 foci per field. Refer to the reference of Lee et al (2016) . B, Alteration of serum ALT (Top panel) and AST (Bottom panel) levels by EPS treatment. Values were expressed as mean 6 SE. Asterisk indicates statistical difference between treatment group and control group (P < .05).
sections from 100 mg/kg EPS-treated mice, indicated by the arrows ( Figure 5D ).
Effect of EPS on Protein Expression of Cytoglobin
Many factors can contribute to liver fibrogenesis, for instance activation of HSCs. Cytoglobin, also called stellate cell activation-associated protein, is commonly used as a biomarker of activation of HSC (Kawada et al., 2001) . In Figure 5B , we showed that EPS increased cytoglobin mRNA expression. To determine whether HSCs are activated, Cytoglobin protein expression was further evaluated. Immunohistochemistry staining showed that as compared with control, administration of 30 mg/kg EPS did not increase cell numbers that are Cytoglobin staining-positive ( Figure 6A) . In contrast, 100 and 300 mg/kg EPS increased the percentage of cells, which are Cytoglobin staining-positive in mouse liver ( Figure 6A ). Western blots further showed that EPS dose-dependently increased Cytoglobin protein expression ( Figure 6B ). Therefore, EPS administration activated HSCs in mouse liver.
EPS Increased Cell Viability of Cultured Human LX-2 HSCs
As shown in Figure 6C , 3 mM of EPS did not alter the cell density of human LX-2 HSCs. 10 and 30 mM of EPS increased the cell density of LX-2 HSCs. However, 100 and 300 mM of EPS decreased LX-2 cell viability. Therefore, EPS increased cell viability of human HSCs at low concentrations but decreased their viability at higher concentrations.
EPS Increased the mRNA Expression of Hif-1a/HIF-1A in Cultured LX-2 Cells and Mouse Liver Cytoglobin gene expression is regulated by hypoxia-inducible factor (Hif) 1 alpha. We next determined the regulation of Hif1a/HIF-1A mRNA by EPS in mouse liver as well as in cultured human LX-2 cells. As shown in Figure 6D , EPS (30 mg/kg) increased Hif-1a mRNA expression 2-fold. In cultured human LX-2 cells, treatment of 10 lM of EPS for 48 h increased mRNA expression of Cytoglobin and HIF-1A 1.3-and 2.9-fold, respectively. Therefore, induction of Hif1a/HIF-1A may contribute to EPS-induced Cytoglobin expression in mouse liver and LX-2 cells.
EPS Increased the mRNA expression of Some InflammationAssociated Genes As shown in Figures 4A and 5A , EPS-induced inflammation. We further assessed the mRNA expression of some inflammationassociated genes by EPS. As shown in Figure 7 , 30 mg/kg EPS only increased CD11b mRNA expression. 100 mg/kg EPS increased mRNA expression of both CD11b and CD11c. Also 300 Connective tissue is stained blue, nuclei are stained dark red/purple, and cytoplasm is stained red/pink. Arrows point to the cells in blue color. mg/kg EPS only increased CD11c mRNA expression. In contrast, all doses of EPS did not apparently alter F4/80, Ly6c, or Ly6g mRNA expression.
DISCUSSION
Previous studies showed that EPS protected endothelial cells and Schwann cells by inhibiting aldose reductase and thus repressing oxidative stress (Sato et al., 2013; Yama et al., 2015 Yama et al., , 2016 . Because its anti-oxidative response, EPS is beneficial to diabetic patients in whom oxidative stress is elevated. However, in our studies, we showed that in cultured mouse and human hepatoma cells as well as in mouse liver, EPS actually induced oxidative stress. Therefore, the effects of EPS on production of oxidative stress are tissue-and cell-specific. In addition to being an aldose reductase inhibitor, EPS is structurally a rhodanine derivative. We further showed that sorbinil, another aldose reductase inhibitor but not a rhodanine derivative, did not alter cell viability of mouse Hepa1c1c7 hepatoma cells. In contrast, two other rhodanine derivatives, namely rhodanine and D-3,4 dichloro pehnoxyl rhodanin, produced oxidative stress and decreased cell viability in cultured mouse Hepa1c1c7 hepatoma cells (unpublished data). Therefore, the adverse effects of EPS on hepatoma cells and possibly mouse liver are primarily due to its inherent rhodanine-like structure feature.
Oxidative stress plays a crucial role in the development of numerous chronic liver diseases including liver fibrogenesis and stimulates their progression. Oxidative stress is primarily generated in the mitochondria. In this study, we showed that EPS increased the expression of Fgf21 and mitochondrial MnSOD, two characteristic biomarkers of mitochondrial stress. These findings indicated that in mouse liver, EPS may interfere with mitochondrial functions. This will be further addressed in our future studies.
In this study, we showed that EPS treatment for 14 days did not acutely increase mouse serum ALT and AST levels. This may explain why EPS is generally recognized as a relative safe drug in humans. In clinical studies, serum ALT and AST levels are often tested, and most likely only tested, to determine whether a drug can produce liver injury. However, during chronic liver injury, such as liver fibrosis, ALT and AST levels will not be acutely elevated, even though liver function is impaired (Bissell, 2001; Guicciardi and Gores, 2005; Murray et al., 2005) . Because the symptoms of liver fibrosis are progressively deteriorated, eventually the ALT levels will be elevated, similarly as observed in EPS post-marketing surveillances.
A previous report showed that EPS ameliorated Bleomycininduced pulmonary fibrosis in rats (Li et al., 2015) . Here we reported that EPS tended to induce liver fibrosis in mice. Liver fibrosis is a chronic liver disease characterized by excessive accumulation of extracellular matrix collagen proteins, which usually results from chronic damage to liver due to chronic hepatic C virus infection, alcohol abuse or drug adverse effects. Impropriate or delayed treatment of liver fibrosis will lead to liver cirrhosis or even liver cancer that will cause hepatic dysfunction or even mortality (Bataller and Brenner, 2005; Friedman, 2003 Friedman, , 2008 . Therefore, it is critical to protect liver from sustained damage. In this study, we showed that EPS induced expression of 2 early biomarker genes of fibrogenesis, namely procollagen I and alpha SMA, and increased collagen deposition. These findings indicated that EPS predisposed to induce liver fibrosis.
One of the hallmarks of liver fibrogenesis is activation of HSCs. Under normal conditions, HSCs are usually in quiescent status with neither proliferation nor secretion. Upon activation, usually after liver injury, HSCs will differentiate into myofibroblast-like cells with a high proliferation rate and migratory ability. Activated HSCs are the major sources of extracellular matrix proteins and also secrete various profibrogenic cytokines such as SMA (Bataller and Brenner, 2005; Friedman, 1999 Friedman, , 2008 . Activation of HSCs is characterized by many factors, for instance increased expression of Cytoglobin. Cytoglobin is exclusively expressed in HSCs but not in myofibroblasts or hepatocytes (Motoyama et al., 2014) . For instance, Cytoglobin was up-regulated in the condition of CCl 4 -induced liver fibrosis along with other fibrosis biomarkers such as procollagen I and SMA mRNA levels (Man et al., 2008) . In this study, we showed that EPS increased mRNA and/or protein levels of Cytoglobin, pro-collagen I, and SMA. In addition, we showed that induction of Hif-1a/HIF-1A may contribute to EPSinduced cytoglobin expression in mouse liver and cultured human LX-2 cells. Moreover, EPS, at low concentrations, directly increased cell viability of human LX-2 HSCs. Therefore, EPS activated HSCs and consequently contributed to its susceptibility to induce liver fibrosis.
In addition to activation of HSCs, many other etiological factors can contribute to liver fibrogenesis, such as inflammation and oxidative stress. We showed that EPS administration produced inflammation in mouse liver, evidenced by increased expression of TNF-a, CD11b, and CD11c, as well as increased infiltration of inflammatory cells, which is very similar to a case report that showed that EPS-induced hepatic injury in a hospital-admitted woman and that there was portal inflammation with infiltrated lymphocytes in the patient's liver (Fujise et al., 2011) . Chronic inflammatory response plays important roles in liver fibrogenesis. For instance, TNF-a plays important roles during endothelial-mesenchymal transition, a process critical for pathogenesis of liver fibrosis. Induction of both CD11b and CD11c in mouse liver indicated that Kupffer cells and/or neutrophils are activated by EPS. Upon activation, Kupffer cells and/or neutrophils release cytokines, produce oxidative stress, stimulate the collagen production, and play a key role in the progression of liver cirrhosis. Therefore, Inflammation may also contribute to EPS predisposition to induce fibrosis.
As discussed earlier, EPS induced inflammation in C57BL/6 wild-type mouse liver. However, a previous report showed that zopolrestat, an analog of EPS, repressed methionine choline deficient (MCD) diet-induced inflammation in diabetic mouse liver via activation of peroxisome proliferator-activated receptor-alpha (PPAR-a) (Qiu et al., 2012) . This study showed that in diabetic (db/db) mouse liver, zopolrestat increased PPAR-a activity and thereby repressed MCD diet-induced inflammation. However, in non-diabetic db/m heterozygous mouse liver, zopolrestat did not activate PPAR-a nuclear receptor (Qiu et al., 2012) . Therefore, zopolrestat activated PPAR-a only in diabetic mouse liver but not in nondiabetic mouse liver. In our studies, we determined the impact of EPS on the regulation of Cyp4a14, a characteristic target gene of PPAR-a signaling, in C57BL/6 wild-type mouse liver. Our results showed that EPS did not apparently induce Cyp4a14 expression (data not shown) in wild-type mouse liver, similarly as zopolrestat did in nondiabetic mouse liver. The variations of animal models between two studies may at least in part, explain the discrepancy between EPS and zopolrestat in their opposite effects on liver inflammatory.
In conclusion, EPS induced oxidative stress in cultured hepatoma cells as well as in mouse liver. EPS decreased cell viability and induced apoptosis in cultured hepatoma cells. In addition, EPS-induced inflammation and predisposed to induce fibrosis in mouse liver. Because of its adverse effects on liver system, we should closely monitor liver function of the patients who receive EPS treatment, especially those on long-term diabetic neuropathy management using EPS regimen.
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